ArticleMedicine2026
Clinical outcomes of pretarsal fullness formation by capsulopalpebral fascia plication with silicone prosthesis implantation and pretarsal fullness surgery.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
- Retracted
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pretarsal fullness, also known as aegyo-sal, is a critical component of periorbital aesthetics, and its absence often contributes to a fatigued or aged appearance. This retrospective study evaluated the outcomes of capsulopalpebral fascia plication combined with silicone prosthesis implantation and pretarsal fullness surgery performed at our institution between August 2021 and August 2024. A total of 68 patients (mean age, 32.6 ± 6.8 years; 91.2% female) were included. All procedures were completed without intraoperative conversion or major complications. The mean operative time was 46.3 ± 8.5 minutes, with minimal blood loss (12.4 ± 3.6 mL). Objective measurements demonstrated significant improvements in pretarsal protrusion (from 1.2 ± 0.5 mm to 2.9 ± 0.6 mm), inferior tarsal curvature (from 2.1 ± 0.7 mm to 4.3 ± 0.9 mm), and vertical eyelid aperture (from 7.8 ± 1.1 mm to 9.6 ± 1.0 mm; all P <.001). Independent evaluator scores improved from 2.1 ± 0.6 to 4.3 ± 0.5, while patient satisfaction scores for aesthetic appearance and naturalness also increased significantly. Overall, 88.2% of patients reported satisfaction, and FACE-Q quality-of-life scores improved from 44.2 ± 8.5 to 78.6 ± 9.3. Early complications, including transient edema (70.6%) and ecchymosis (32.4%), resolved spontaneously, whereas late complications, such as prosthesis displacement (2.9%), malposition (2.9%), and asymmetry (4.4%), were infrequent and manageable. These findings support the procedure as a safe, effective, and reproducible method for achieving natural pretarsal fullness and enhancing lower-eyelid contour.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.